Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CYTK stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CYTK investment potential.

What is CYTK stock price today?

Get real-time CYTK stock price, historical data, and price charts on Financhill. Track CYTK performance with our advanced analysis tools.

Is CYTK a good investment?

Evaluate CYTK investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CYTK stock?

To buy CYTK stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CYTK?

View detailed market capitalization data and company valuation metrics for CYTK on our comprehensive analysis page.

What is the P/E ratio of CYTK?

Use our fundamental analysis tools to view CYTK P/E ratio and compare valuation metrics with industry peers.

What are CYTK earnings?

View CYTK earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cytokinetics, Inc. 10K Form

Sell

CYTK
Cytokinetics, Inc.

Last Price:

$66.55

Seasonality Move:

9.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10	10Q	CYTK/Cytokinetics, Inc. Quarterly
2023-11-03	10Q	CYTK/Cytokinetics, Inc. Quarterly
2023-08-03	10Q	CYTK/Cytokinetics, Inc. Quarterly
2023-05-05	10Q	CYTK/Cytokinetics, Inc. Quarterly
2022-11-04	10Q	CYTK/Cytokinetics, Inc. Quarterly
2022-08-05	10Q	CYTK/Cytokinetics, Inc. Quarterly

Receive CYTK News And Ratings

See the #1 stock for the next 7 days that we like better than CYTK

CYTK Financial Statistics

Sales & Book Value

Annual Sales:	$18.5M
Cash Flow:	$-116.9M
Price / Cash Flow:	0
Annual Sales:	$-4.27
Price / Book:	61.87

Profitability

EPS (TTM):	-6.30920
Net Income (TTM):	$-751.9M
Gross Margin:	$8.9M
Return on Equity:	0%
Return on Assets:	-55.59%

Cytokinetics, Inc. Earnings Forecast

Key Cytokinetics, Inc. Financial Ratios

The Gross Profit Margin over the past 20 years for CYTK is 48.41%.
The Selling, General & Administrative Expenses for CYTK have been equal to 1,165.50% of Gross Profit Margin.
The Research & Development expenses have been 1,785.63% of Revenue.
The Net Earning history of CYTK is -3,191.11% of Total Revenues.
Per Share Earnings over the last 25 years have been positive in 13 years.

Cytokinetics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	CYTK
CUSIP:	23282W
Website:	cytokinetics.com

Debt

Debt-to-Equity Ratio:	-2.3
Current Ratio:	6.88
Quick Ratio:	6.81

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

CYTK Technical Analysis vs Fundamental Analysis